MedTrace Logo

Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability

NCT03302312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2018-07-30

No results posted yet for this study

Summary

This qualitative study will use focus groups, small group interviews, and individual interviews (both in person and over the phone) to compile a range of perspectives on service members' decision-making processes and information needs related to Stellate Ganglion Block (SGB). Participants will include service members, spouses, and providers.

Conditions

Sponsors & Collaborators

  • Womack Army Medical Center

    collaborator FED

  • Tripler Army Medical Center

    collaborator FED

  • Landstuhl Regional Medical Center

    collaborator FED

  • RTI International

    lead OTHER

Principal Investigators

  • Bradford B Walters, MD, PhD, MBA · RTI International

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-03
Primary Completion
2018-03-02
Completion
2018-03-02

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03302312 on ClinicalTrials.gov